Login
Search
Search
0 Dates
2024
2023
2022
2021
2020
2019
2018
0 Events
CPC 2018
CPC 2019
Curso de Atualização em Medicina Cardiovascular 2019
Reunião Anual Conjunta dos Grupos de Estudo de Cirurgia Cardíaca, Doenças Valvulares e Ecocardiografia da SPC
CPC 2020
CPC 2021
CPC 2022
CPC 2023
CPC 2024
0 Topics
A. Basics
B. Imaging
C. Arrhythmias and Device Therapy
D. Heart Failure
E. Coronary Artery Disease, Acute Coronary Syndromes, Acute Cardiac Care
F. Valvular, Myocardial, Pericardial, Pulmonary, Congenital Heart Disease
G. Aortic Disease, Peripheral Vascular Disease, Stroke
H. Interventional Cardiology and Cardiovascular Surgery
I. Hypertension
J. Preventive Cardiology
K. Cardiovascular Disease In Special Populations
L. Cardiovascular Pharmacology
M. Cardiovascular Nursing
N. E-Cardiology / Digital Health, Public Health, Health Economics, Research Methodology
O. Basic Science
P. Other
0 Themes
01. History of Cardiology
02. Clinical Skills
03. Imaging
04. Arrhythmias, General
05. Atrial Fibrillation
06. Supraventricular Tachycardia (non-AF)
07. Syncope and Bradycardia
08. Ventricular Arrhythmias and Sudden Cardiac Death (SCD)
09. Device Therapy
10. Chronic Heart Failure
11. Acute Heart Failure
12. Coronary Artery Disease (Chronic)
13. Acute Coronary Syndromes
14. Acute Cardiac Care
15. Valvular Heart Disease
16. Infective Endocarditis
17. Myocardial Disease
18. Pericardial Disease
19. Tumors of the Heart
20. Congenital Heart Disease and Pediatric Cardiology
21. Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure
22. Aortic Disease
23. Peripheral Vascular and Cerebrovascular Disease
24. Stroke
25. Interventional Cardiology
26. Cardiovascular Surgery
27. Hypertension
28. Risk Factors and Prevention
29. Rehabilitation and Sports Cardiology
30. Cardiovascular Disease in Special Populations
31. Pharmacology and Pharmacotherapy
32. Cardiovascular Nursing
33. e-Cardiology / Digital Health
34. Public Health and Health Economics
35. Research Methodology
36. Basic Science
37. Miscellanea
0 Resources
Abstract
Slides
Vídeo
Report
CLEAR FILTERS
Left Main Artery Lesions- The role of IVUS and Coronary Physiology
Session:
Posters (Sessão 6 - Écran 7) - Intervenção Coronária e Estrutural 4 - Doença coronária
Speaker:
Rita Rocha
Congress:
CPC 2022
Topic:
H. Interventional Cardiology and Cardiovascular Surgery
Theme:
25. Interventional Cardiology
Subtheme:
25.2 Coronary Intervention
Session Type:
Pósters Electrónicos
FP Number:
---
Authors:
Rita Caldeira da Rocha; Diogo Brás; Francisco Dias Cláudio; Miguel Carias; António Almeida; Ângela Bento; David Neves; Renato Fernandes; Sandra Nunes; Tânia Emerenciano; Marisa Serrano; Manuel Trinca; Lino Patrício
Abstract
<p style="text-align:justify"><strong>Introduction:</strong> LMA lesions have a major impact on patients’ prognosis. Consequently, their additional characterization using image or physiology evaluation(PE) is extremely important. However, with PE little information is given about plaque morphology or stability. Imaging lacks data about physiological impact of anatomically significant lesions.</p> <p style="text-align:justify"><strong>Purpose:</strong>The aim of this study is to determine the prevalence and impact of treatment decision failure of ambiguous LMA lesions assessed by physiology evaluation and/or IVUS.</p> <p style="text-align:justify"><strong>Methods:</strong> Retrospective study, including all consecutive patients who performed PE (iFR, RFR or FFR, and, when clinically necessary, iFR followed by FFR) and/or IVUS (Volcano<sup>TM</sup>)of LMA lesion in our center between June 2010 and December 2020, with clinical follow-up.The primary endpoint of this follow-up was defined as clinically-driven target lesion(TL)revascularization(TLR), TL was defined as the treated segment,when treated(due to positive PE/IVUS),or the evaluated segment, when deferred (negative PE/IVUS). Additionally, acute coronary syndrome(ACS)was sought after.</p> <p style="text-align:justify"><strong>Results:</strong> A total of 140 LMA evaluations of 125 patients were analyzed during a median follow-up of 63[37-97]months, minimum of 12months and maximum of 140months.Male patients accounted for 67%, with a mean age of 67±10years old. Hypertension was present in 91%, diabetes and prior coronary artery disease in 40%each and smoking habits in 46%. Lesion characterization by imaging technique was performed in 83 and PE in 57cases (39 rest evaluations and 26 stress exams). Image and functional tests were performed in 14patients.</p> <p style="text-align:justify">The initial treatment plan was changed in 25% of the patients due to IVUS and in 32% with PE. The decision of revascularization was made using both techniques in 4cases,and of differing intervention in 10, of whom 2 presented with TLR. Therapy decision based on IVUS was changed due to PE in 5cases, the opposite happened in just 1patient.</p> <p style="text-align:justify">In only 1 case PE wasn’t measured, due to technical problems, which weren’t reported with IVUS. No clinical complications were reported.</p> <p style="text-align:justify">Primary endpoint was achieved in 4%,with 4 cases with IVUS evaluations and in 3 with PE, not having a statistical difference. Globally, ACS was found in 10%of patients after a median follow-up of 24[19;43]months.</p> <p style="text-align:justify"><strong>Conclusion:</strong> LMA revascularization decision based on IVUS and/or physiology evaluation proved to be useful, changing the initial treatment strategy in almost a third of the cases, and safe(target lesion revascularization of 4%).</p>
Slides
Our mission: To reduce the burden of cardiovascular disease
Visit our site